SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-000872
Filing Date
2021-01-12
Accepted
2021-01-12 07:14:58
Documents
50
Period of Report
2021-01-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nc10017928x10_8k.htm   iXBRL 8-K 42969
2 EXHIBIT 99.1 nc10017928x10_ex99-1.htm EX-99.1 94218
3 EXHIBIT 99.2 nc10017928x10_ex99-2.htm EX-99.2 30977
7 nc10017928x10_ex99-1slide1.jpg GRAPHIC 883136
8 nc10017928x10_ex99-1slide2.jpg GRAPHIC 2292100
9 nc10017928x10_ex99-1slide3.jpg GRAPHIC 622587
10 nc10017928x10_ex99-1slide4.jpg GRAPHIC 599978
11 nc10017928x10_ex99-1slide5.jpg GRAPHIC 591957
12 nc10017928x10_ex99-1slide6.jpg GRAPHIC 894834
13 nc10017928x10_ex99-1slide7.jpg GRAPHIC 583825
14 nc10017928x10_ex99-1slide8.jpg GRAPHIC 513783
15 nc10017928x10_ex99-1slide9.jpg GRAPHIC 651973
16 nc10017928x10_ex99-1slide10.jpg GRAPHIC 788749
17 nc10017928x10_ex99-1slide11.jpg GRAPHIC 798358
18 nc10017928x10_ex99-1slide12.jpg GRAPHIC 919628
19 nc10017928x10_ex99-1slide13.jpg GRAPHIC 748425
20 nc10017928x10_ex99-1slide14.jpg GRAPHIC 1005936
21 nc10017928x10_ex99-1slide15.jpg GRAPHIC 627199
22 nc10017928x10_ex99-1slide16.jpg GRAPHIC 1257660
23 nc10017928x10_ex99-1slide17.jpg GRAPHIC 1175288
24 nc10017928x10_ex99-1slide18.jpg GRAPHIC 523088
25 nc10017928x10_ex99-1slide19.jpg GRAPHIC 466191
26 nc10017928x10_ex99-1slide20.jpg GRAPHIC 490072
27 nc10017928x10_ex99-1slide21.jpg GRAPHIC 637686
28 nc10017928x10_ex99-1slide22.jpg GRAPHIC 783692
29 nc10017928x10_ex99-1slide23.jpg GRAPHIC 846735
30 nc10017928x10_ex99-1slide24.jpg GRAPHIC 737000
31 nc10017928x10_ex99-1slide25.jpg GRAPHIC 645009
32 nc10017928x10_ex99-1slide26.jpg GRAPHIC 766008
33 nc10017928x10_ex99-1slide27.jpg GRAPHIC 766636
34 nc10017928x10_ex99-1slide28.jpg GRAPHIC 554203
35 nc10017928x10_ex99-1slide29.jpg GRAPHIC 1004315
36 nc10017928x10_ex99-1slide30.jpg GRAPHIC 792101
37 nc10017928x10_ex99-1slide31.jpg GRAPHIC 872687
38 nc10017928x10_ex99-1slide32.jpg GRAPHIC 853799
39 nc10017928x10_ex99-1slide33.jpg GRAPHIC 928858
40 nc10017928x10_ex99-1slide34.jpg GRAPHIC 636217
41 nc10017928x10_ex99-1slide35.jpg GRAPHIC 400577
42 nc10017928x10_ex99-2image01.jpg GRAPHIC 62184
  Complete submission text file 0001140361-21-000872.txt   38248152

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alxn-20210112.xsd EX-101.SCH 4192
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxn-20210112_lab.xml EX-101.LAB 22718
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxn-20210112_pre.xml EX-101.PRE 16214
43 EXTRACTED XBRL INSTANCE DOCUMENT nc10017928x10_8k_htm.xml XML 4076
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 21522408
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences